From an Enterprise to an Era

May 19 – 20, 2022 • Ritz-Carlton Laguna Niguel, Dana Point, CA

Organizing Committee

The 16th Annual Personalized Medicine Conference is being organized by a cross-industry, cross-disciplinary panel, made up of providers, payers, educators, researchers and other stakeholders — all of whom believe that collaborative dialogue is essential to the advancement of personalized medicine.


President, Personalized Medicine Coalition

Bonnie J. Addario
Co-Founder, Chair, GO2 Foundation for Lung Cancer

Antonio L. Andreu, M.D., Ph.D.
Scientific Director, EATRIS (European Infrastructure for Translational Medicine)

Mandy Bazile
Director, Government Affairs, Genentech

Mary Bordoni
Director, Strategic Alliance Development, Bristol Myers Squibb

William S. Dalton, Ph.D., M.D.
Founder, Executive Chairman, M2Gen

Robert W. Dubois, M.D., Ph.D.
Interim President and CEO, National Pharmaceutical Council

Stephen L. Eck, M.D., Ph.D.
Chief Medical Officer, MacroGenics

Okan Ekinci, M.D., M.B.A.
Chief Medical Officer, Roche Diagnostics Information Solutions

Lori Frank, Ph.D.
Memory Screening Advisory Board Member, Alzheimer’s Foundation of America

Richard Hamermesh, D.B.A.
Co-Faculty Chair, Harvard Business School Kraft Precision Medicine Accelerator

Kris Joshi, Ph.D.
Executive Vice President, President, Network Solutions, Change Healthcare

Richard Knight
President, American Association of Kidney Patients

Anne-Marie Martin, Ph.D.
Senior Vice President, Global Head of Experimental Medicine, GlaxoSmithKline

Susan McClure
Founder, CEO, Genome Creative

Howard McLeod, Pharm.D.

Tom Miller
Founder, Managing Partner, GreyBird Ventures LLC

Lincoln Nadauld, M.D., Ph.D.
Chief, Precision Health, Intermountain Healthcare

Michael J. Pellini, M.D.
Managing Partner, Section 32

Ammar Qadan
Vice President, Global Head of Market Access, Illumina

Hakan Sakul, Ph.D.
Vice President, Head of Diagnostics, Worldwide Research & Development, Pfizer

Michael Sherman, M.D.
Executive Vice President, Chief Medical Officer, Point32Health

Lauren Silvis
Senior Vice President, External Affairs, Tempus

Ralph Snyderman, M.D.
James B. Duke Professor of Medicine, Duke University

Mark P. Stevenson
Executive Vice President, Chief Operating Officer, Thermo Fisher Scientific

Bernadette Toner
CEO, GenomeWeb

Apostolia M. Tsimberidou, M.D., Ph.D.
Tenured Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Alex Vadas, Ph.D.
Managing Director, Partner, LEK Consulting

Werner Verbiest
Strategic Partnerships and Alliances Leader, Janssen Pharmaceutical Companies of Johnson & Johnson

Jay G. Wohlgemuth, M.D.
Chief Medical Officer, Senior Vice President, Quest Diagnostics